Artivion | CRY - Stock


Artivion reported $92.43M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Accuray USD 155.5M 14.48M Sep/2025
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 92.43M 1.88M Dec/2025
AtriCure USD 78.49M 459K Dec/2025
Baxter International USD 2.23B 228M Dec/2025
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Boston Scientific USD 2.94B 22M Dec/2025
Edwards Lifesciences USD 1.14B 800K Sep/2025
Inogen USD 25.08M 762K Sep/2025
Integra LifeSciences USD 492.73M 3.63M Dec/2025
J&J USD 14.19B 45M Dec/2025
Mesa Laboratories USD 26.56M 1.18M Dec/2025
Orthofix International USD 172.32M 1.72M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
ResMed USD 922.04M 23.76M Dec/2025
Stryker USD 5.31B 60M Dec/2025
Surmodics USD 15.17M 230K Sep/2024
Tandem Diabetes Care USD 128.77M 8.51M Dec/2025
Teleflex USD 802.46M 108.78M Sep/2025
Terumo JPY 311.91B 10.92B Sep/2025
Trinity Biotech USD 19.16M 210K Sep/2025